This lecture was supported by Grant Number 6H79FG000999-01M001 from SAMHSA. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of SAMHSA. 

About the speaker

Dr. Janet Wozniak is an Associate Professor of Psychiatry at Harvard Medical School and at Massachusetts General Hospital. After receiving her BA from Harvard College, Dr. Wozniak completed medical school at Cornell Medical University. She completed residencies in adult, child, and adolescent psychiatry at Massachusetts General Hospital. Dr. Wozniak has been honored with a Massachusetts General Hospital Women's Careers Faculty Development Award. Dr. Wozniak's research focuses on the course, characteristics, and pharmacological treatment of juvenile onset bipolar disorder.  Her research has been supported by the Stanley Research Foundation, NARSAD and public service grants from the National Institutes of Mental Health. She is widely regarded as an expert in pediatric bipolar disorder.

Disclosure Statements

Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME), and the American Medical Association (AMA), all planners, reviewers, speakers and persons in control of content have been asked to disclose any relationship he/she has with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt, and if there will be discussion of any products, services, or off-label uses of product(s) during this presentation.

Janet Wozniak, MD, reported receiving royalties from Bantam Books and research support from PCORI, Demarest Lloyd Jr. Foundation, and the Baszucki Brain Research Fund, in the past 24 months.. She will discuss the off-label use of mood stabilizers/medication in pediatrics using generic terms. All conflicts of interest have been mitigated though review. 

Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months: Todd Peters, MD, Deepak Prabhakar, MD, Elizabeth Ryznar, MD, MSc, Louis Marino, MD, Ehsan Syed, MD, Devi Bhuyan, PsyD, Faith Dickerson, PhD, Carrie Etheridge, LCSW-C, Tom Flis, LCPC, Stacey Garnett, RN, MSN, Stephanie M. Robinson, MSN, RN, PMH-BC, NPD-BC, NE-BC , Heather Billings, RN, Lisa Illum, MLIS, MEd, and Jennifer Tornabene.